Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer
Authors:
- Sujitha JayaprakashSJSujitha Jayaprakash
- Mangala HegdeMHMangala Hegde
- Sosmitha GirisaSGSosmitha Girisa
- Mohammed S. AlqahtaniMAMohammed S. Alqahtani
- Mohamed AbbasMAMohamed Abbas
- E. Hui Clarissa LeeELE. Hui Clarissa Lee
- Kenneth Chun-Hong YapKYKenneth Chun-Hong Yap
- Gautam SethiGautam Sethi
- Alan Prem KumarAlan Prem Kumar
- Ajaikumar B. KunnumakkaraAKAjaikumar B. Kunnumakkara
Open Access
- 19 September 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (18) , 10952
Abstract
Esophageal cancer (EC), an aggressive and poorly understood disease, is one of the top causes of cancer-related fatalities. GLOBOCAN 2020 reports that there are 544,076 deaths and 604,100 new cases expected worldwide. Even though there are various advancements in treatment procedures, this cancer has been reported as one of the most difficult cancers to cure, and to increase patient survival; treatment targets still need to be established. Nuclear receptors (NRs) are a type of transcription factor, which has a key role in several biological processes such as reproduction, development, cellular differentiation, stress response, immunity, metabolism, lipids, and drugs, and are essential regulators of several diseases, including cancer. Numerous studies have demonstrated the importance of NRs in tumor immunology and proved the well-known roles of multiple NRs in modulating proliferation, differentiation, and apoptosis. There are surplus of studies conducted on NRs and their implications in EC, but only a few studies have demonstrated the diagnostic and prognostic potential of NRs. Therefore, there is still a paucity of the role of NRs and different ways to target them in EC cells to stop them from spreading malignancy. This review emphasizes the significance of NRs in EC by discussing their diverse agonists as well as antagonists and their response to tumor progression. Additionally, we emphasize NRs’ potential to serve as a novel therapeutic target and their capacity to treat and prevent EC.Keywords
Funding Information
- Department of Biotechnology (DBT), Government of India (RMBH/PNH/SB/12/2015-1438)
- Deanship of Scientific Research at King Khalid University (KKU) (R.G.P.1/256/43)
- Yong Loo Lin School of Medicine, National University of Singapore
- President’s Ph.D. Scholarship, National University of Singapore
- Ministry of Education - Singapore (MOE-T2EP30120-0016)
This publication has 257 references indexed in Scilit:
- Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic responseCancer Letters, 2013
- Targeting PPARγSignaling Cascade for the Prevention and Treatment of Prostate CancerPPAR Research, 2012
- Biology of Barrett's Esophagus and Esophageal AdenocarcinomaGastrointestinal Endoscopy Clinics of North America, 2011
- Structural and functional insights into nuclear receptor signalingAdvanced Drug Delivery Reviews, 2010
- Ligand docking and binding site analysis with PyMOL and Autodock/VinaJournal of Computer-Aided Molecular Design, 2010
- Steroid receptor phosphorylation: Assigning function to site‐specific phosphorylationBioFactors, 2009
- Butanol fraction containing berberine or related compound from nexrutine® inhibits NFκB signaling and induces apoptosis in prostate cancer cellsThe Prostate, 2008
- Estrogen and its receptors in cancerMedicinal Research Reviews, 2008
- Tumor-suppressive activity of retinoic acid receptor-β in cancerCancer Letters, 2007
- Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene productsBiochemical Pharmacology, 2007